KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Revenue (2016 - 2026)

Merck has reported Revenue over the past 18 years, most recently at $16.3 billion for Q1 2026.

  • Quarterly Revenue rose 4.87% to $16.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $65.8 billion through Mar 2026, up 2.89% year-over-year, with the annual reading at $65.0 billion for FY2025, 1.31% up from the prior year.
  • Revenue was $16.3 billion for Q1 2026 at Merck, down from $16.4 billion in the prior quarter.
  • Over five years, Revenue peaked at $17.3 billion in Q3 2025 and troughed at $13.8 billion in Q4 2022.
  • The 5-year median for Revenue is $15.8 billion (2024), against an average of $15.6 billion.
  • Year-over-year, Revenue skyrocketed 49.63% in 2022 and then dropped 8.89% in 2023.
  • A 5-year view of Revenue shows it stood at $13.8 billion in 2022, then grew by 5.78% to $14.6 billion in 2023, then rose by 6.79% to $15.6 billion in 2024, then grew by 4.97% to $16.4 billion in 2025, then decreased by 0.7% to $16.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Revenue are $16.3 billion (Q1 2026), $16.4 billion (Q4 2025), and $17.3 billion (Q3 2025).